Literature DB >> 28965767

Jak1 Integrates Cytokine Sensing to Regulate Hematopoietic Stem Cell Function and Stress Hematopoiesis.

Maria Kleppe1, Matthew H Spitzer2, Sheng Li3, Corinne E Hill1, Lauren Dong1, Efthymia Papalexi1, Sofie De Groote1, Robert L Bowman1, Matthew Keller1, Priya Koppikar1, Franck T Rapaport4, Julie Teruya-Feldstein5, Jorge Gandara6, Christopher E Mason6, Garry P Nolan7, Ross L Levine8.   

Abstract

JAK1 is a critical effector of pro-inflammatory cytokine signaling and plays important roles in immune function, while abnormal JAK1 activity has been linked to immunological and neoplastic diseases. Specific functions of JAK1 in the context of hematopoiesis, and specifically within hematopoietic stem cells (HSCs), have not clearly been delineated. Here, we show that conditional Jak1 loss in HSCs reduces their self-renewal and markedly alters lymphoid/myeloid differentiation in vivo. Jak1-deficient HSCs exhibit decreased competitiveness in vivo and are unable to rescue hematopoiesis in the setting of myelosuppression. They exhibit increased quiescence, an inability to enter the cell cycle in response to hematopoietic stress, and a marked reduction in cytokine sensing, including in response to type I interferons and IL-3. Moreover, Jak1 loss is not fully rescued by expression of a constitutively active Jak2 allele. Together, these data highlight an essential role for Jak1 in HSC homeostasis and stress responses.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Jak1; cytokine signaling; hematopoietic stem cells; stress hematopoiesis

Mesh:

Substances:

Year:  2017        PMID: 28965767      PMCID: PMC5847260          DOI: 10.1016/j.stem.2017.08.011

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  43 in total

Review 1.  Hematopoietic cytokine receptor signaling.

Authors:  S J Baker; S G Rane; E P Reddy
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

2.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

Review 3.  Jaks and Stats in signaling by the cytokine receptor superfamily.

Authors:  J N Ihle; I M Kerr
Journal:  Trends Genet       Date:  1995-02       Impact factor: 11.639

Review 4.  The future of JAK inhibition in myelofibrosis and beyond.

Authors:  John O Mascarenhas; Nicholas C P Cross; Ruben A Mesa
Journal:  Blood Rev       Date:  2014-06-28       Impact factor: 8.250

5.  Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1.

Authors:  Grant A Challen; Nathan C Boles; Stuart M Chambers; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2010-03-05       Impact factor: 24.633

6.  IFNalpha activates dormant haematopoietic stem cells in vivo.

Authors:  Marieke A G Essers; Sandra Offner; William E Blanco-Bose; Zoe Waibler; Ulrich Kalinke; Michel A Duchosal; Andreas Trumpp
Journal:  Nature       Date:  2009-02-11       Impact factor: 49.962

7.  Enrichment map: a network-based method for gene-set enrichment visualization and interpretation.

Authors:  Daniele Merico; Ruth Isserlin; Oliver Stueker; Andrew Emili; Gary D Bader
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

8.  An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor.

Authors:  Nicholas G Wysham; Donald R Sullivan; Gopal Allada
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors.

Authors:  Cornelis J H Pronk; Ole Petter Veiby; David Bryder; Sten Eirik W Jacobsen
Journal:  J Exp Med       Date:  2011-07-18       Impact factor: 14.307

10.  Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells.

Authors:  Amanda L Blasius; Winfried Barchet; Marina Cella; Marco Colonna
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

View more
  26 in total

Review 1.  Janus kinases to jakinibs: from basic insights to clinical practice.

Authors:  Massimo Gadina; Mimi T Le; Daniella M Schwartz; Olli Silvennoinen; Shingo Nakayamada; Kunihiro Yamaoka; John J O'Shea
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

Review 2.  JAK/STAT signaling in stem cells and regeneration: from Drosophila to vertebrates.

Authors:  Salvador C Herrera; Erika A Bach
Journal:  Development       Date:  2019-01-29       Impact factor: 6.868

Review 3.  New Concepts of Treatment for Patients with Myelofibrosis.

Authors:  Prithviraj Bose; Mansour Alfayez; Srdan Verstovsek
Journal:  Curr Treat Options Oncol       Date:  2019-01-24

4.  An evolutionary recent IFN/IL-6/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans.

Authors:  Murilo Delgobo; Daniel Agb Mendes; Edgar Kozlova; Edroaldo Lummertz Rocha; Gabriela F Rodrigues-Luiz; Lucas Mascarin; Greicy Dias; Daniel O Patrício; Tim Dierckx; Maíra A Bicca; Gaëlle Bretton; Yonne Karoline Tenório de Menezes; Márick R Starick; Darcita Rovaris; Joanita Del Moral; Daniel S Mansur; Johan Van Weyenbergh; André Báfica
Journal:  Elife       Date:  2019-10-22       Impact factor: 8.140

5.  PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia.

Authors:  Helen M McRae; Alexandra L Garnham; Yifang Hu; Matthew T Witkowski; Mark A Corbett; Mathew P Dixon; Rose E May; Bilal N Sheikh; William Chiang; Andrew J Kueh; Tan A Nguyen; Kevin Man; Renee Gloury; Brandon J Aubrey; Antonia Policheni; Ladina Di Rago; Warren S Alexander; Daniel H D Gray; Andreas Strasser; Edwin D Hawkins; Stephen Wilcox; Jozef Gécz; Axel Kallies; Matthew P McCormack; Gordon K Smyth; Anne K Voss; Tim Thomas
Journal:  Blood       Date:  2019-02-12       Impact factor: 22.113

6.  T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.

Authors:  S Takashima; M L Martin; S A Jansen; Y Fu; J Bos; D Chandra; M H O'Connor; A M Mertelsmann; P Vinci; J Kuttiyara; S M Devlin; S Middendorp; M Calafiore; A Egorova; M Kleppe; Y Lo; N F Shroyer; E H Cheng; R L Levine; C Liu; R Kolesnick; C A Lindemans; A M Hanash
Journal:  Sci Immunol       Date:  2019-12-06

7.  Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.

Authors:  Stephen P Persaud; Julie K Ritchey; Sena Kim; Sora Lim; Peter G Ruminski; Matthew L Cooper; Michael P Rettig; Jaebok Choi; John F DiPersio
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

Review 8.  JAK-STAT in Early Hematopoiesis and Leukemia.

Authors:  Eirini Sofia Fasouli; Eleni Katsantoni
Journal:  Front Cell Dev Biol       Date:  2021-05-14

9.  Ruxolitinib ameliorates progressive anemia and improves survival during episodes of emergency granulopoiesis in Fanconi C-/- mice.

Authors:  Shirin Hasan; Liping Hu; Olatundun Williams; Elizabeth A Eklund
Journal:  Exp Hematol       Date:  2022-03-09       Impact factor: 3.084

Review 10.  Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

Authors:  Klara Klein; Dagmar Stoiber; Veronika Sexl; Agnieszka Witalisz-Siepracka
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.